臨床婦人科産科76巻10号

2022年10月発行

今月の臨床 女性医学から読み解くメタボリック症候群―専門医のための必須知識 疾患・分野別編

がん治療によるメタボリック症候群への影響―肥満・脂質異常・心血管疾患・糖尿病を中心に

著者： 佐々木浩¹

所属機関： ¹大阪医科薬科大学産婦人科

ページ範囲：P.1017 - P.1021

●がん患者は手術・化学療法・放射線治療の影響とともに生活習慣も変化することからメタボリック症候群になりやすい．

●外科的閉経は肥満・脂質異常・心血管疾患・糖尿病におけるリスクファクターとなる．

●がん治療後も長期的な健康管理を行うことは重要である．

参考文献

1）Son J, et al : Adoptive cell therapy in gynecologic cancers : a systematic review and meta-analysis. Gynecol Oncol 165 : 664-670, 2022

2）Kim M, et al : Increased prevalence of metabolic syndrome in adult cancer survivors : Asian first report in community setting. Cancer Epidemiol 58 : 130-136, 2019

3）Fang Q, et al : Weight gain during neoadjuvant chemotherapy is associated with worse outcome among the patients with operable breast cancer. J Breast Cancer 22 : 399-411, 2019

4）Kokts-Porietis RL, et al : Prospective cohort study of metabolic syndrome and endometrial cancer survival. Gynecol Oncol 158 : 727-733,2020

5）Nonaka M, et al : Cancer treatment-related cardiovascular disease : current status and future research priorities. Biochem Pharmacol 190 : 114599, 2021

6）Rocca WA, et al : Accelerated accumulation of multimorbidity after bilateral oophorectomy : a population-based cohort study. Mayo Clin Proc 91 : 1577-1589, 2016

7）Ohmichi M, et al : Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas 25 : 125-131, 2003

8）Arca M, et al : Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. JAMA 271 : 453-459, 1994

9）Ikenoue N, et al : Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstet Gynecol 93 : 566-570, 1999

10）Hirasawa A, et al : Hypertriglyceridemia is frequent in endometrial cancer survivors. Jpn J Clin Oncol 43 : 1087-1092,2013

11）Mouridsen H, et al : Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen : safety analysis of BIG 1-98 trial. Cancer 98 : 5715-5722, 2003

12）Watanabe A, et al : Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients : a pilot study Int J Clin Oncol 20 : 829-838, 2015

13）Saito Y, et al : Severe hypertriglyceridemia induced by docetaxel : a novel case report. Case Rep Oncol 9 : 1277-1282, 2021

14）Zamorano JL, et al : 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology（ESC）. Eur Heart J 37 : 2768-2801, 2016

15）Barnard K : Viewpoint : an explanation for the cardiovascular effects of bevacizumab and rofecoxib? Circulation 114 : 173-175, 2006

16）Hu JR, et al : Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res 115 : 854-868, 2019

17）Xiao Y, et al : Increased risk of diabetes in cancer survivors : a pooled analysis of 13 population-based cohort studies. ESMO Open 6 : 100218, 2021

18）Roeland EJ, et al : Management of cancer cachexia : ASCO Guideline. J Clin Oncol 38 : 2438-2453, 2020

19）Porporato PE : Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5 : e200, 2016

20）Grimes A, et al : Hyperglycemia during childhood cancer therapy : incidence, implications, and impact on outcomes. J Natl Cancer Inst Monogr 54 : 132-138, 2019

21）Ansari MJ, et al : The programmed death-1（PD-1） pathway regulates autoimmune diabetes in nonobese diabetic（NOD）mice. J Exp Med 198 : 63-69, 2003

22）Yoneda S, et al : T-lymphocyte infiltration to islets in the pancreas of a patient who developed type 1 diabetes after administration of immune checkpoint inhibitors. Diabetes Care 42 : e116-e118, 2019

23）Michelsen TM, et al : Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer : a controlled observational study. Eur J Cancer 45 : 82-89, 2009